Literature DB >> 10502408

Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.

J F Siddiqui1, D Van Mater, M P Sowden, H C Smith.   

Abstract

Apolipoprotein B (apoB) mRNA editing is a site-specific (nucleotide 6666) cytidine to uridine transition catalyzed by a cytidine deaminase, APOBEC-1, in the context of a multiprotein complex referred to as the C/U editosome. This report quantifies for the first time the effect of altering APOBEC-1 protein abundance on the proportion of edited apoB mRNAs using transfected McArdle rat hepatoma cells which had been sorted by flow cytometry into populations expressing different levels of green fluorescent protein-APOBEC-1 chimera, GFP-APOBEC. A correlation was observed in which increased expression of GFP-APOBEC protein resulted in a higher proportion of edited apoB mRNA. The number of enzyme molecules required to increase the proportion of edited apoB RNAs was disproportionately high relative to that which might have been predicted from a typical catalytic relationship. Moreover, editing of apoB mRNA at inappropriate sites (promiscuous editing) occurred in response to overexpressing GFP-APOBEC. The data suggest that experimental manipulation of APOBEC-1 abundance in the absence of other regulatory considerations will always result in some level of promiscuous editing. Coordinate expression of APOBEC-1 and the auxiliary proteins and/or regulation of their interactions may be required to increase editing activity without losing editing-site fidelity. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502408     DOI: 10.1006/excr.1999.4598

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Hypermutation induced by APOBEC-1 overexpression can be eliminated.

Authors:  Zhigang Chen; Thomas L Eggerman; Alexander V Bocharov; Irina N Baranova; Tatyana G Vishnyakova; Gyorgy Csako; Amy P Patterson
Journal:  RNA       Date:  2010-03-26       Impact factor: 4.942

2.  Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing.

Authors:  Z Chen; T L Eggerman; A P Patterson
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

3.  Identification of the yeast cytidine deaminase CDD1 as an orphan C-->U RNA editase.

Authors:  G S Dance; P Beemiller; Y Yang; D V Mater; I S Mian; H C Smith
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

4.  Intestine-specific expression of Apobec-1 rescues apolipoprotein B RNA editing and alters chylomicron production in Apobec1 -/- mice.

Authors:  Valerie Blanc; Yan Xie; Jianyang Luo; Susan Kennedy; Nicholas O Davidson
Journal:  J Lipid Res       Date:  2012-09-19       Impact factor: 5.922

5.  Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.

Authors:  Martin Hersberger; Susannah Patarroyo-White; Xiaobing Qian; Kay S Arnold; Lucia Rohrer; Maureen E Balestra; Thomas L Innerarity
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

6.  Targeted deletion of the murine apobec-1 complementation factor (acf) gene results in embryonic lethality.

Authors:  Valerie Blanc; Jeffrey O Henderson; Elizabeth P Newberry; Susan Kennedy; Jianyang Luo; Nicholas O Davidson
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

7.  Commitment of apolipoprotein B RNA to the splicing pathway regulates cytidine-to-uridine editing-site utilization.

Authors:  M P Sowden; H C Smith
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

8.  APOBEC-1 dependent cytidine to uridine editing of apolipoprotein B RNA in yeast.

Authors:  G S Dance; M P Sowden; Y Yang; H C Smith
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

9.  Flow-cytometric visualization of C>U mRNA editing reveals the dynamics of the process in live cells.

Authors:  Francesco Severi; Silvestro G Conticello
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.